Comparative in-vitro activity of levofloxacin against Chlamydia spp.

被引：3
作者：
Donati, M
Rumpianesi, F
Marchetti, F
Sambri, V
Cevenini, R [1 ]
机构：
[1] Osped S Orsola, DMCSS, Sez Microbiol, Bologna, Italy
[2] Hoechst Mar Roussel, Dept Med, Milan, Italy
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 1998年 / 42卷 / 05期
关键词：
D O I：
10.1093/jac/42.5.670
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：670 / 671
页数：2
相关论文
共 6 条
  • [1] CEVENINI R, 1987, FEMS MICROBIOL LETT, V42, P47, DOI 10.1111/j.1574-6968.1987.tb02297.x
  • [2] The clinical pharmacokinetics of levofloxacin
    Fish, DN
    Chow, AT
    [J]. CLINICAL PHARMACOKINETICS, 1997, 32 (02) : 101 - 119
  • [3] INVITRO ACTIVITIES OF 5 QUINOLONES AGAINST CHLAMYDIA-PNEUMONIAE
    HAMMERSCHLAG, MR
    HYMAN, CL
    ROBLIN, PM
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (03) : 682 - 683
  • [4] OFLOXACIN VERSUS DOXYCYCLINE FOR TREATMENT OF CERVICAL INFECTION WITH CHLAMYDIA-TRACHOMATIS
    HOOTON, TM
    BATTEIGER, BE
    JUDSON, FN
    SPRUANCE, SL
    STAMM, WE
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (05) : 1144 - 1146
  • [5] Chlamydiae as pathogens: New species and new issues
    Peeling, RW
    Brunham, RC
    [J]. EMERGING INFECTIOUS DISEASES, 1996, 2 (04) : 307 - 319
  • [6] In vitro activity of trovafloxacin against Chlamydia pneumoniae
    Roblin, PM
    Kutlin, A
    Hammerschlag, MR
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (09) : 2033 - 2034
1